All In Biotech

Drug Trial Radar · NCT07634484

A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins

A Post-Marketing Clinical Trial of Pemafibrate in Patients With Hypercholesterolemia and Inadequate Response to Statins-Multicenter, Placebo Controlled, Randomized, Double Blind, Parallel Group Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jul 1, 2026

Primary completion

Jul 31, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Kowa Company, Ltd.Industry
Sponsor type
Industry
First posted
Jun 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate the efficacy and safety of Pemafibrate 0.2 mg/day or 0.4 mg/day for 12 weeks in patients with hypercholesterolemia and inadequate response to statins, using placebo as a control.

Conditions

  • Hypercholesterolemia

Interventions

  • Pemafibrate 0.2 mg/dayDrug

    Administered orally once daily

  • Pemafibrate 0.4 mg/dayDrug

    Administered orally once daily

  • PlaceboDrug

    Administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change from baseline in LDL-C (direct)Time frame: 4, 8, and 12 weeks after administration

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • NTT Medical Center Sapporo

    Hokkaido, Japan · Recruiting

  • Ami Higashi Clinic

    Ibaraki, Japan · Recruiting

  • Olive Takamatsu Medical Clinic

    Kagawa, Japan · Recruiting

  • Medical Corporation Shintokai Yokohama Minoru Clinic

    Kanagawa, Japan · Recruiting

  • Medical Corporation Heishinkai OCROM Clinic

    Osaka, Japan · Recruiting

  • Hirose Clinic

    Saitama, Japan · Recruiting

  • Medical Corporation Yukeikai Asano Internal Medicine Clinic

    Saitama, Japan · Recruiting

  • Medical Corporation Asbo Tokyo Asbo Clinic

    Tokyo, Japan · Recruiting

  • Medical Corporation Heishinkai ToCROM Clinic

    Tokyo, Japan · Recruiting

  • Shimokitazawa Tomo Clinic

    Tokyo, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.